Towa Pharmaceutical Co., Ltd.
【Towa Pharmaceutical】Share Buyback and Introduction of Director Compensation System | June 2026
Towa Pharmaceutical decided at its Board of Directors meeting on June 24, 2026, to dispose of 1,188 shares of treasury stock in accordance with its director compensation system, with the disposal scheduled for July 10. The purpose is to enhance corporate value and motivate management, with the restriction period for transfer of the disposed shares set at 30 years.
Key Figures
- Number of shares to be disposed: 1,188 shares
- Payment amount: 4,555,980 yen
- Payment amount per share: 3,835 yen
AI要約
Overview of the disposal
Towa Pharmaceutical has decided to dispose of 1,188 shares of treasury stock as part of its restricted stock compensation system based on its director compensation制度. The disposal date is scheduled for July 10, 2026, with a payment amount of 3,835 yen per share and a total of 4,555,980 yen. The targeted directors are three members of the Board of Directors. The purpose is to enhance corporate value and motivate management. The transfer restriction period is set at 30 years, a long-term period.
Purpose of the disposal and future outlook
This disposal aims to increase directors' awareness of enhancing corporate value and promote long-term sharing of shareholder value. The disposed shares are managed with transfer restrictions, and they can be transferred under certain conditions or after continuous service. The long-term incentive structure is designed to support sustained corporate growth and shareholder value improvement.
Towa Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
